Uncategorized

Element Announces Expanded Customer Base, New Products, and Unprecedented Capabilities on a Benchtop Sequencer

Element Biosciences, Inc., developer of pioneering technologies to empower science, has received over 160 commercial orders of its AVITI benchtop sequencer and expanded its installed base to 112 instruments, the company announced at the J.P. Morgan 42nd Annual Healthcare Conference.

Element Announces Expanded Customer Base, New Products, and Unprecedented Capabilities on a Benchtop Sequencer Read More »

Scroll to Top